GANX Projected Dividend Yield
Gain Therapeutics Inc ( NASDAQ : GANX )Gain Therapeutics, Inc. is a biotechnology company. Co. is focused on developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, central nervous system (CNS) disorders, lysosomal storage disorders (LSDs), metabolic disorders, and other diseases that can be targeted through protein degradation, such as oncology. Co.'s drug discovery platform, Magellan discovers novel allosteric binding sites on proteins implicated in a disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. 20 YEAR PERFORMANCE RESULTS |
GANX Dividend History Detail GANX Dividend News GANX Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |